CardioGen-82® (Rubidium Rb 82 Generator) offers diagnostic confidence, safety, and efficiency plus the professional training, service, and expertise Bracco is known for.​

Since 1989, Bracco has been building upon its legacy of leadership in cardiac positron emission tomography (PET) myocardial perfusion imaging (MPI) and the field of nuclear medicine. ​We were the first to invest heavily in cardiac PET MPI, and our continued commitment to the patients we serve each day is evident in the passion of our dedicated and experienced team. Join the growing number of world-class cardiac care facilities and teaching institutions that have discovered the benefits and clinical value of cardiac PET MPI with CardioGen-82 (Rubidium Rb 82 Generator).

See what the experts have to say.

See what the experts and patients of Cardiovascular Institute of the South in Houma, Louisiana have to say about the benefits of cardiac PET.

CardioGen-82 Full Prescribing Information

Indications, Usage, and Important Safety Information:

Indications and Usage:
CARDIOGEN-82® (Rubidium Rb 82 Generator) is a closed system used to produce Rubidium Rb 82 chloride injection for intravenous administration. Rubidium Rb 82 chloride injection is a radioactive diagnostic agent indicated for positron emission tomography (pet) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

IMPORTANT SAFETY INFORMATION:

Indications and Usage:
CardioGen-82® (Rubidium Rb 82 Generator) is a closed system used to produce Rubidium Rb 82 chloride injection for intravenous administration. Rubidium Rb 82 chloride injection is a radioactive diagnostic agent indicated for positron emission tomography (pet) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

IMPORTANT SAFETY INFORMATION:

WARNING: HIGH LEVEL RADIATION EXPOSURE WITH USE OF INCORRECT ELUENT AND FAILURE TO FOLLOW THE ELUATE TESTING PROTOCOL
Please see full prescribing information for complete boxed warning

High Level Radiation Exposure with Use of Incorrect Eluent
Using the incorrect eluent can cause high Strontium (Sr) 82 and Sr 85 breakthrough levels (5.1)

  • Use only additive-free 0.9% Sodium Chloride Injection USP to elute the generator (2.4)
  • Immediately stop the patient infusion and permanently discontinue the use of the affected CardioGen-82® generator if the incorrect solution is used to elute the generator (4)
  • Evaluate the patient’s radiation absorbed dose and monitor for the effects of radiation to critical organs such as bone marrow (2.7)

Excess Radiation Exposure with Failure to Follow the Eluate Testing Protocol
Excess radiation exposure occurs when the levels of Sr 82 or Sr 85 in the rubidium Rb 82 chloride injection exceed limits. (5.2)

  • Record eluate volume, including waste and test volumes (2.4)
  • Strictly adhere to the generator eluate testing protocol (2.5)
  • Stop using the generator if it reaches any of its Expiration Limits (2.6)

Please see full Prescribing Information for CardioGen-82® (Rubidium Rb 82 Generator) including boxed WARNING by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/MedWatch/ or call 1-800-FDA-1088.

CardioGen-82 is manufactured for Bracco Diagnostics Inc., Monroe Township, NJ 08831, by GE Healthcare, Medi-Physics, Inc., South Plainfield, NJ 07080. 

We are Cardiac PET is a trademark of Bracco Diagnostics Inc.

CardioGen-82 is a registered trademark of Bracco Diagnostics Inc.